Search the
company directory

AnyGrain International AG 

Zug · Since 2023

The core activity of AnyGrain International AG is the international trade in grains and grain products, including the purchase and sale of grains, oilseeds and legumes for the production of flour, animal feed, oil and green fuel.

Apellis Schweiz GmbH 

Zug · Since 2023

Apellis Schweiz GmbH is a biopharmaceutical company that develops medicines that inhibit the complement cascade, with a particular focus on the complement protein C3. Its pipeline and approved products target conditions such as geographic atrophy, C3 glomerulopathy/primary immune complex‑mediated membranoproliferative glomerulonephritis, and paroxysmal nocturnal hemoglobinuria, and the site cites products including Empaveli and Syfovre.

Apellis International GmbH 

Zug · Since 2019

Apellis International GmbH develops medicines that inhibit the complement cascade by targeting the central protein C3. Its products include the C3‑targeting medicines EMPAVELI® and SYFOVRE®, and the company advances clinical and preclinical programs across ophthalmology, hematology, nephrology and gene-/RNA‑based therapeutic approaches.

apfeleins.group AG 

Zug · Since 2023

apfeleins.group AG is a strategic holding that invests in digital business models and holds stakes in technology and Web3 companies. The group supports early‑stage startups with strategic guidance, operates service formats for networking and knowledge exchange, and publishes a magazine.

APFL GmbH 

Zug · Since 2023

APFL GmbH provides consulting, development and distribution of construction materials and related system solutions, focusing on paints, plasters, mineral fillers and waterproofing and flowable compounds. The company works with German manufacturers in a B2B supply model and offers both standard products and customized or private-label options.

Aphaia Pharma AG 

Zug · Since 2018

The core activity of Aphaia Pharma AG is the development and marketing of pharmaceuticals, particularly in the fields of life sciences and biotechnology. The company focuses on the research and development of innovative therapeutics and medications, particularly in the areas of microvascular medicine and the treatment of diseases such as obesity and metabolic disorders.

Aplanis Consulting GmbH 

Zug · Since 2011

The core activity of Aplanis Real Estate is Asset & Property Management, which involves the management and optimization of properties and real estate for clients. This includes long-term planning, identifying potential and creating value through comprehensive market knowledge and experience in the field of Asset & Property Management.

APM Trans4mation AG 

Zug · Since 2019

The core activity of Martin à Porta Executive Advisory is to advise companies in the areas of leadership, transformation and personnel development, with the goal of building high-performance organizations. This also includes services such as keynote speaking and the development of strategies for sustainable leadership and talent management.

Apollon Wealth AG 

Zug · Since 2018

Apollon Wealth AG provides asset management and investment advisory services and operates the Apollon Wealth platform. The company performs active portfolio management, applies systematic risk management, an 80:20 investment approach and algorithmic analysis to select investments, and arranges execution through selected Swiss banking partners.

Appian Software International GmbH 

Zug · Since 2012

The company provides software solutions and services to financial service providers to reduce operational risks and increase agility. The core activities include: Connected Onboarding and Servicing, KYC software solutions for process automation, Customer Lifecycle Management, Governance, Risk and Compliance, Lending and Payment Transactions, and Enterprise Functions. The company supports financial service providers in automating processes, improving customer relationships, and complying with regulations.